According to Alaunos Therapeutics's latest financial reports the company's current EPS (TTM) is -2,11ย โฌ. In 2022 the company made an earnings per share (EPS) of -23,35ย โฌ an increase over its 2021 EPS that were of -48,00ย โฌ.